top of page

4

No.

VIEW DETAILS

Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea

​작성자 |

이한길, Ah-Young Kim, Deborah Baik, Hyeonseok Cho, Jung Woo Han, Minjun Lee, Seonyoung Park, Hye-Young Kang

[논문] 이한길, Ah-Young Kim, Deborah Baik, Hyeonseok Cho, Jung Woo Han, Minjun Lee, Seonyoung Park, Hye-Young Kang, Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea , HAEMOPHILIA (Jan, 2021)

https://www2.ajou.ac.kr/pharm/professor/professor01.jsp?include=view&article_no=202110069&board_wrapper=%2Fpharm%2Fprofessor%2Fprofessor01.jsp&pager.offset=0&board_no=249

이한길, Ah-Young Kim, Deborah Baik, Hyeonseok Cho, Jung Woo Han, Minjun Lee, Seonyoung Park, Hye-Young Kang

bottom of page